AK Medical Holdings Limited (HKG:1789)
5.61
-0.10 (-1.75%)
Sep 18, 2025, 4:08 PM HKT
AK Medical Holdings Revenue
AK Medical Holdings had revenue of 694.23M CNY in the half year ending June 30, 2025, with 7.02% growth. This brings the company's revenue in the last twelve months to 1.38B, up 25.51% year-over-year. In the year 2024, AK Medical Holdings had annual revenue of 1.35B with 23.08% growth.
Revenue (ttm)
1.38B CNY
Revenue Growth
+25.51%
P/S Ratio
4.15
Revenue / Employee
1.45M CNY
Employees
954
Market Cap
6.30B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.35B | 252.52M | 23.08% |
Dec 31, 2023 | 1.09B | 41.82M | 3.97% |
Dec 31, 2022 | 1.05B | 290.61M | 38.17% |
Dec 31, 2021 | 761.44M | -273.95M | -26.46% |
Dec 31, 2020 | 1.04B | 108.68M | 11.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
JD Health International | 71.34B |
Hansoh Pharmaceutical Group Company | 14.45B |
Innovent Biologics | 12.52B |
WuXi Biologics | 21.98B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |